by Miquel Estevez | Mar 4, 2022 | News
Winter sleep (hibernation) offers hibernating species the possibility to survive harsh environmental conditions, such as periods of low food availability or periods of extreme low temperatures. Hibernators lower their body temperature, breathing- and heart rate and...
by Vincent Schermer | Aug 24, 2021 | News
Groningen, The Netherlands & Ankara, Turkey – Sulfateq BV, an early stage biotech company developing a group of small molecules that maintain mitochondrial health, and GEN İlaç ve Sağlık Ürünleri Sanayi ve Ticaret A.Ş. (GEN), a publicly traded company...
by Daniel | May 18, 2021 | News
Sulfateq is happy to announce that a new scientific manuscript detailing the efficacy of SUL-151 to mitigate the development of Chronic Obstructive Pulmonary Disease (COPD), was recently published in the International Journal of Molecular Sciences. This manuscript...
by Raymond Tel | Dec 14, 2020 | News
Groningen, The Netherlands & Ankara, Turkey – Sulfateq BV, an early stage biotech company developing a group of small molecules that maintain mitochondrial health, and GEN İlaç ve Sağlık Ürünleri Sanayi ve Ticaret A.Ş. (GEN), a leading speciality...
by Raymond Tel | Feb 25, 2020 | News
We are proud to announce that Sulfateq B.V. received a Samenwerkingsverband Noord-Nederland (SNN) Valorisation grant for the development of SUL-138 as Acute Kidney Injury (AKI) prophylaxis. This grant helps us to continue the development that was already stimulated by...
by Thomas Kuipers | Jan 13, 2020 | News
There is a new manuscript available which describes the positive effect of our SUL-109 compound which is commercially available as our ROKEPIE preservation solution. This article was written by Fatima Aerts from the Hacettepe University in Ankara (Turkey). You can...